Impact of a pharmacy resident on hospital length of stay and drug-related costs

Annals of Pharmacotherapy

Volumn 41, Issue 5, 2007, Pages 742-748

  Terceros, Yvonne ^a,b,c   Chahine Chakhtoura, Corinne ^a,d   Malinowski, Judith E ^d,e   Rickley, William F ^a,f  

^a ST MICHAEL S MEDICAL CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Mountainside Hospital   (United States)

^d SETON HALL UNIVERSITY   (United States)

^e UNIVERSITY OF NEW ENGLAND   (United States)

^f OVERLOOK HOSPITAL   (United States)

Author keywords

Impact; Interventions; Medical rounds; Pharmacy resident

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL PHARMACY; CONTROL GROUP; CONTROLLED STUDY; COST CONTROL; DEMOGRAPHY; DRUG COST; EVALUATION; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MEDICAL RECORD; MEDICATION ERROR; PATIENT MONITORING; PHARMACIST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESIDENT;

ADULT; AGED; AGED, 80 AND OVER; COST SAVINGS; DRUG COSTS; FEMALE; HOSPITALIZATION; HUMANS; INTERNSHIP, NONMEDICAL; LENGTH OF STAY; MALE; MEDICATION ERRORS; MIDDLE AGED; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL;

EID: 34248596947     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H603     Document Type: Article

References (24)

1. Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy 2004;24:1491-8. DOI 10.1592/phco.24.16.1491.50950
2. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Baurman JL. Evidence of economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003;23:113-32. DOI 10.1592/phco.23.1.113.31910
3. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care. Arch Intern Med 2006;166:955-64. DOI 10.1001/archinet.166.9.955
4. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005;39:1423-7. Epub 26 Jul 2005. DOI 10.1345/aph.1E640
5. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000;20:1508-16. DOI 10.1592/phco.20.19.1508.34852
6. Bouvy ML, Heerdink ER, Urquahart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail 2003;9:404-11. DOI 10.1054/S1071-9164(03)00130-1
7. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994;22:906-9. DOI 10.1097/00003246-1994060000-00027
8. Chandler C, Barriuso P, Rozenberg-Ben-Dror K, Schmitt B. Pharmacists on a primary care team at a Veterans Affairs medical center. Am J Health Syst Pharm 1997;54:1280-7.
9. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166:565-71. DOI 10.1001/archinte.166.5.565
10. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014-8. DOI 10.1001/archinte.163.17. 2014
11. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-70. DOI 10.1001/jama.282.3.267
12. Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B. Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 2002;30:919-21. DOI 10.1097/00003246-200204000-00035
13. Miyagawa CI, Rivera JO. Effect of pharmacist interventions on drug therapy costs in a surgical intensive care unit. Am J Hosp Pharm 1986; 43:3008-13.
14. Bozek PS, Perdue BE, Bar-Din M, Weidle PJ. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health Syst Pharm 1998;55:1151-5.
15. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999;159:2306-9. DOI 10.1001/archinte.159.19.2306
16. Chuang LC, Sutton JD, Henderson GT. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit. Hosp Pharm 1994;29:215-8,221.
17. Durbin CG Jr. Team model: advocating for the optimal method of care delivery in the intensive care unit. Crit Care Med 2006;34(suppl):S12-7. DOI 10.1097/01.CCM.0000199985.72497.D1
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
19. Yoshida E. Workload and cost-benefit of hospital pharmacy residents. Can J Hosp Pharm 1993;46:147-54.
20. Carter JT, Draugalis JR, Slack MK. Impact of clerkship students on pharmacy-site output. Am J Health Syst Pharm 1996;53:1694-700.
21. Slack MK, Draugalis JR. Models for estimating the impact of clerkship students on pharmacy practice sites. Am J Hosp Pharm 1994;51:525-30.
22. Leroy ML, Pruemer J. Impact of an oncology pharmacy residency training program on quality improvement initiatives in an oncology center. Pharm Pract Manag Q 1996;16:59-65.
23. Franke RH, Kaul JD. The Hawthorne experiments: first statistical interpretation. Am Sociol Rev 1978;43:623-43. DOI 10.2307/2094540
24. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. N Engl J Med 1991;324:370-6.